OCS Competitors & Alternatives
Compare Oculis Holding AG Ordinary shares with similar stocks in the same industry
Biotechnology
OCS
Main Stock$10.56
Tradestie Score
45
Market Cap
$910.64M
Revenue Growth
0.2%
Analyst Upside
+239.7%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$150.13
|
$699.30M | - | 54 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.73
|
$688.47M | - | 43 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 49 | Compare |
|
ARVN
Arvinas, Inc
|
$8.45
|
$670.30M | 33.5 | 33 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$12.79
|
$665.30M | 14.8 | 41 | Compare |
|
MPLT
MPLT
|
$13.00
|
$639.32M | - | 31 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$15.88
|
$626.91M | - | 57 | Compare |
|
SVRA
Savara Inc.
|
$5.30
|
$611.84M | - | 50 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 49 | Compare |
|
CTMX
CytomX Therapeutics, Inc.
|
$3.29
|
$552.46M | - | 48 | Compare |
More OCS Analysis
Data updated: Sep 12, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry